CLARA - Cancéropôle Lyon Auvergne Rhône-Alpes
Created in 2003
Social networks
3,126 5,387Activities
Entity types
Location
213 Rue de Gerland Bâtiment C, 69007 Lyon, France
Lyon
France
Employees
Scale: 2-10
Estimated: 18
SIREN
337607303Engaged corporates
36
10 28Added in Motherbase
5 years, 1 month ago
biotech Value proposition
The goal of the Cancéropôle (cancer cluster) Lyon Auvergne Rhône-Alpes (CLARA) is to structure and facilitate cancer research in the French Rhône-Alpes Auvergne inter region by bringing together academic, clinical and industrial strengths in order to develop a network with a European dimension.
CLARA is distinct from the six other French cancéropôles due to its amplitude of funding by local authorities.
This particular feature confers strong economic objectives, on top of the objectives related to scientific excellence and public health as presented in the French Cancer Plans.
An important feature of CLARA’s strategy is to promote cancer research applications with clear industrial objectives.
The CLARA Cancer Research Cluster strives to bringing together researchers, clinicians and industrial partners into a single network, and to pool their efforts on operational research programs with a two-fold objective of quickly transferring knowledge to patient care and developing marketable applications of research findings.
From the laboratory to industrial production, CLARA constitutes a missing link by promoting the industrial transfer and commercial development of an idea.
Leading a program to support innovative, high-potential projects in the area of health/oncology/biotechnology, called “Proof of Concept”, the Cancéropôle is making a difference, confirming its role as a dynamic actor of economic development.
Cancer Cluster, Cancer Research Network, Proof of Concept, Academic/clinical and Industrial Partnerships, Oncology Scientific Events, Regulatory Issues related to Clinical Transfer, recherche clinique, vulgarisation scientifique, événement scientifique, financement de projets de recherche, and internationalOriginal language
Sur la base d'une initiative régionale impulsée en 2001, le
Cancéropôle Lyon Auvergne-Rhône-Alpes est soutenu par les
pouvoirs publics depuis 2003 dans le cadre des Plans Cancer
nationaux. Il a pour objectif de développer et valoriser la recherche
en cancérologie en Auvergne-Rhône-Alpes.
Le CLARA est un animateur de réseau. Il fédère les acteurs
académiques, nationaux et internationaux de lutte contre le cancer
dans un double objectif : le transfert rapide des découvertes vers les
patients et la valorisation économique de la recherche.
www.canceropole-clara.com
Le Cancéropôle est soutenu par la Fondation Innovation et Transitions.
Accueil - Cancéropôle Lyon Auvergne Rhône-Alpes – CLARA
https://www.canceropole-clara.com/?doing_wp_cron=1715321468.9033250808715820312500
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 GSK Pharmaceutical, Pharmaceutical Manufacturing | GSK Pharmaceutical, Pharmaceutical Manufacturing | Other 8 Apr 2023 | | |
 Saint-Étienne Métropole Government Administration, French metropolis | Saint-Étienne Métropole Government Administration, French metropolis | Other 31 Mar 2024 | | |
 incubateur-accélérateur emlyon business school Professional Training & Coaching | incubateur-accélérateur emlyon business school Professional Training & Coaching | Other 7 Nov 2017 | | |
 INRAE Research, Research Services | INRAE Research, Research Services | Other 9 Oct 2023 | | |
 Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Other 19 Feb 2020 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 6 Apr 2021 16 Mar 2023 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 25 Feb 2019 8 Apr 2023 | | |
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 9 Apr 2021 7 Nov 2022 | | |
 Linksium Venture Capital and Private Equity Principals | Linksium Venture Capital and Private Equity Principals | Other 15 Mar 2022 27 Sep 2023 | | |
 MEDICALPS Business Consulting and Services | MEDICALPS Business Consulting and Services | Other 23 Apr 2024 | | |